NIPP-1, a Nuclear Inhibitory Subunit of Protein Phosphatase-1, Has RNA-binding Properties*

(Received for publication, June 10, 1997)

Izabela Jagiello , Monique Beullens Dagger , Veerle Vulsteke , Stefaan Wera Dagger , Björn Sohlberg §, Willy Stalmans , Alexander von Gabain § and Mathieu Bollen

From the Afdeling Biochemie, Faculteit Geneeskunde, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium and § Institute of Microbiology and Genetics, Vienna Biocenter, University of Vienna, A-1030 Vienna, Austria

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
Note added in proof
REFERENCES


ABSTRACT

NIPP-1 is a nuclear inhibitory subunit of protein phosphatase-1 with structural similarities to some proteins involved in RNA processing. We report here that baculovirus-expressed recombinant NIPP-1 displays RNA-binding properties, as revealed by North-Western analysis, by UV-mediated cross-linking, by RNA mobility-shift assays, and by chromatography on poly(U)-Sepharose. NIPP-1 preferentially bound to U-rich sequences, including RNA-destabilizing AUUUA motifs. NIPP-1 also associated with single-stranded DNA, but had no affinity for double-stranded DNA. The binding of NIPP-1 to RNA was blocked by antibodies directed against the COOH terminus of NIPP-1, but was not affected by prior phosphorylation of NIPP-1 with protein kinase A or casein kinase-2, which decreases the affinity of NIPP-1 for protein phosphatase-1. The catalytic subunit of protein phosphatase-1 did not bind to poly(U)-Sepharose, but it bound very tightly after complexation with NIPP-1. These data are in agreement with a function of NIPP-1 in targeting protein phosphatase-1 to RNA.


INTRODUCTION

The type 1 protein phosphatases (PP-1)1 represent a conserved family of Ser/Thr-specific protein phosphatases with functions in various cellular processes including metabolism, intracellular transport, and protein synthesis (1, 2). PP-1 is particularly abundant in the nucleus, where it is involved in the regulation of both transcription and mRNA processing. As for the latter, PP-1 has a demonstrated role in the subnuclear distribution of pre-mRNA splicing factors, spliceosome assembly, and (alternative) pre-mRNA processing, which has been explained by dephosphorylation of components of small nuclear ribonucleoproteins (snRNPs), such as the "SR" proteins, by PP-1 (3-5). The SR splicing factors share a common motif of Ser-Arg repeats that is reversibly phosphorylated in vivo and is essential for spliceosome assembly and function.

All known species of PP-1 are dimeric or trimeric enzymes (1, 2). They contain an isoform of the same catalytic subunit (PP-1C), but differ in the regulatory subunits. In addition to an activity-controlling and substrate-specifying function, the regulatory subunits also have a "targeting" role. This multifunctional role is best understood for the "G" subunit that anchors PP-1 to glycogen and promotes the dephosphorylation of glycogen-associated proteins like glycogen synthase (6, 7). Similarly, the "M" subunit targets PP-1 to myofibrils and enhances the dephosphorylation of myosin (6, 7). Other noncatalytic subunits of PP-1 (e.g. inhibitor-2, NIPP-1, and sds22) are known to affect the activity and/or substrate specificity of PP-1 in vitro, but it is unclear at present whether they also have a targeting role (1, 2, 8, 9).

NIPP-1 is a nuclear polypeptide that potently and specifically inhibits PP-1C (8). It can be extracted from the insoluble nuclear fraction as a heterodimeric complex with PP-1C, termed PP-1NNIPP-1 (10). Phosphorylation of intact NIPP-1 (39 kDa) or its inhibitory core (16-18 kDa) by protein kinase A and/or casein kinase-2 reduces its affinity for PP-1C (10-13). The inhibitory site and all the phosphorylation sites for protein kinase A and casein kinase-2 reside in the central third of the polypeptide (13).2 The cDNA cloning of bovine NIPP-1 has revealed a limited structural similarity with the 70-kDa U1-RNA-associated protein (13), which is a component of the U1 snRNP complex in the spliceosome (14). Also, the COOH-terminal third of NIPP-1 (13)2 is identical to a human polypeptide of 13 kDa that can reverse the pleiotropic effects of deletion mutants of a 5'-segment of the rne gene in Escherichia coli. The latter protein was named Ard-1, for "activator of RNA decay," since it restored deficient RNA processing in the bacterial rne mutants (15). The complementation by Ard-1 is not easily understood at the molecular level, since the rne gene encodes a multifunctional protein that not only displays an endoribonuclease E (RNase E) activity, but also contains domains that have been implicated in RNA binding, in macromolecular transport and in the maintenance of the cytoskeleton.

The established role of PP-1 in RNA-processing and the structural similarities between NIPP-1 and known RNA-processing enzymes have prompted us to investigate the potential RNA-binding properties of NIPP-1. We report here that NIPP-1 binds with high affinity to RNA, in particular to U-rich sequences. By analogy with the anchoring role of other regulatory subunits of PP-1, we propose that NIPP-1 targets PP-1 to RNA-associated substrates.


EXPERIMENTAL PROCEDURES

Preparation and Assay of Proteins

NIPP-1 from bovine thymus was expressed in insect Sf9 cells under control of the polyhedrin promotor, using the baculovirus expression system.3 48-72 h after infection of the Sf9 cells with the recombinant virus, NIPP-1 could be detected as a major polypeptide in the cell extracts. The recombinant NIPP-1 was purified until homogeneity by successive chromatographies on heparin-Sepharose (Pharmacia Biotech Inc.) and Poros HQ (Perseptive Biosystems) columns.

The spontaneous and trypsin-revealed phosphorylase phosphatase activities were measured as described by Jagiello et al. (10). NIPP-1 was detected by Western blotting with polyclonal antibodies raised against the 11 carboxyl-terminal residues of NIPP-1, by an overlay with digoxygenin-labeled PP1C, and by the assay as an inhibitor of PP-1C (10). Protein concentrations were measured according to Bradford (16). Endoribonuclease activities, using AU4 and 9 S RNA as substrates, were measured as detailed in Wennborg et al. (17).

Preparation and Labeling of RNA and Oligo(deoxy)ribonucleotides

The homoribopolymers poly(A), poly(C), poly(G), and poly(U) were purchased from Sigma. The following oligoribonucleotides were obtained from Eurogentec (Liège, Belgium): AG1, 5'-CUCUAGAGGAUGCAGGUAAGCUUGGGUACCG-3'; AU1, 5'-CUCUAGAGGAUGCAUUUAAGCUUGGGUACCG-3'; AU2, 5'-CUAGAGGAUGCAUUUAUUUAAGCUUGGGUAC-3'; AU4, 5'-AGGAUGCAUUUAUUUAUUUAUUUAAGCUUGG-3'; and AUMYC, 5'-CUUUAACAGAUUUGUAUUUAAGAAUUGUUUUUAAAAAAUUUUAAGAUUUACACA-3' (17). Oligodeoxyribonucleotides were synthesized using a Cyclone DNA synthetizer (New Brunswick): dAT4, 5'-AGGATGCATTTATTTATTTATTTAAGCTTGG-3' and dTA4, 5'-CCAAGCTTAAATAAATAAATAAATGCATCCT-3'. dAT4 and dTA4 were annealed by incubation of both oligos (each at 0.5 mg/ml) in 10 mM Tris/HCl at pH 7.5, 1 mM EDTA, and 10 mM MgCl2 during 10 min at 95 °C, followed by a slow acclimatization to room temperature.

E. coli 9 S RNA and mRNA encoding outer membrane protein A (ompA) were transcribed from 2 µg of the HaeIII-linearized plasmids pTH90 and p106B-64, respectively, using the in vitro transcription kit from Stratagene and [alpha 32P]CTP (16). Subsequently, the DNA templates were removed by incubation (30 min at 37 °C) with 400 units/ml RNase-free DNase I (Pharmacia) in the presence of 600 units/ml RNase inhibitor RNAsin (Promega). The labeled probes were extracted with a mixture of phenol/chloroform/isoamylalcohol (25:24:1), precipitated with 70% (v/v) ethanol and 10 mM sodium acetate, and purified on 8% urea-PAGE. The labeled RNA was visualized by autoradiography and extracted with 10 mM Tris/HCl at pH 7.5 and 1 mM EDTA. The probes were once more extracted and precipitated as detailed above, lyophilized, and resuspended in 10 mM Tris/HCl at pH 7.5 and 1 mM EDTA.

The oligoribonucleotides AG1, AU1, AU2, AU4, and AUMYC were labeled at the 5'-end by phosphorylation with T4 polynucleotide kinase (Boehringer Mannheim) during 45 min at 37 °C, according to the manufacturer's instructions, in the presence of [gamma -32P]ATP and 600 units/ml RNAsin. The labeled oligonucleotides were purified on 20% urea-PAGE and extracted as detailed above for RNA.

UV-mediated Cross-linking

NIPP-1 (5 µg/ml) or bovine serum albumin (25 µg/ml) were incubated in 10 mM Tris/HCl at pH 7.5, 0.05% (v/v) Triton X-100, 40 mM KCl, 3 mM dithiothreitol, 8.5% (v/v) glycerol, 2 mM MgCl2, and 5 mM EDTA with 5'-end-labeled AU4 (2 µCi/ml), or the 5'-untranslated region of the ompA mRNA (1 µCi/ml), or else 9 S RNA (1 µCi/ml) as described previously (17). Aliquots of 20 µl were exposed to UV light (254 nm at 250 mJ for 1 min) in a Stratalinker UV apparatus. Subsequently, the samples were subjected to 7.5% Tricine-SDS-PAGE, and the dried gels were exposed for autoradiography.

North-Western Blot Analysis

NIPP-1 was subjected to 7.5% Tricine-SDS-PAGE and blotted onto nitrocellulose membranes (Hybond-C extra, Amersham Corp.) Prehybridization was performed for 90 min at 44 °C in a buffer containing 10 mM Tris/HCl at pH 8.0, 1 mM EDTA, 50 mM NaCl, 1 mM dithiothreitol, 0.02% Ficoll, 0.02% polyvinylpyrrolidone, 0.02% bovine serum albumin, and 150 µg/ml preheated (10 min at 100 °C followed by an incubation at 0 °C) salmon sperm DNA (Sigma). The hybridization was done for 2 h at 44 °C in the same buffer supplemented with in vitro transcribed 9 S RNA (0.2 µCi/ml) or 5'-end-labeled AG1 or AU4 (0.4 µCi/ml). Subsequently, the membranes were washed four times for 10 min in 10 mM Tris/HCl at pH 8.0, 1 mM EDTA, 50 mM NaCl, and 1 mM dithiothreitol, and the radioactive bands were visualized by autoradiography.

RNA Mobility Assays

Various proteins (1-25 µg/ml) were incubated for 30 min at 0 °C in a buffer containing 10 mM Hepes at pH 7.5, 40 mM KCl, 3 mM dithiothreitol, 8.5% (v/v) glycerol, 2 mM MgCl2, 0.05 mM EDTA, 0.05% (v/v) Triton X-100, and one of the 5'-end-labeled oligoribonucleotides, or in vitro transcribed 9 S RNA, or else the 5'-untranslated region of the ompA mRNA (1-2 µCi/ml). Electrophoresis was carried out for 2 h at 4 °C at 200 V using 5% native PAGE in 0.1 M Tris plus 0.1 M glycine. The dried gels were analyzed by autoradiography.


RESULTS

Identification of NIPP-1 as an RNA-binding Protein

The present study was performed with bovine thymus NIPP-1 that was expressed in insect Sf9 cells, using the baculovirus expression system, and purified until homogeneity (Fig. 1, left panel). The properties of the isolated recombinant inhibitor were similar to those of native NIPP-1 (10) and of the NIPP-1 fragments that were previously isolated from bovine thymus (8, 11-12), with respect to the specificity and potency of its inhibition of PP-1C, and the decreased inhibitory potency after its phosphorylation by protein kinase A and casein kinase-2 (not illustrated).


Fig. 1. Identification of NIPP-1 as an RNA-binding protein by North-Western analysis and by UV-mediated cross-linking. Left panel, NIPP-1 (1-5 µg/lane) was subjected to 7.5% Tricine-SDS-PAGE and blotted onto nitrocellulose membranes. The lanes were either stained with Amido Black or subjected to autoradiography after hybridization with 32P-labeled 9 S RNA, AU4, or AG1 as indicated. Right panel, 5'-end-labeled AU2 (50 ng/ml) was incubated either as such or in the presence of native NIPP-1 (5 µg/ml) or bovine serum albumin (25 µg/ml) and subjected to UV-mediated cross-linking prior to electrophoresis and autoradiography.
[View Larger Version of this Image (24K GIF file)]

Since it has been reported that the COOH-terminal third of NIPP-1 can substitute for some functions of the bacterial RNase E (see Introduction), we have initially focused on known substrates of this endoribonuclease to investigate putative RNA-binding properties of NIPP-1. These substrates include "9 S RNA" (the bacterial precursor of 5 S ribosomal RNA), the ompA mRNA, and the oligoribonucleotides AG1, AU1, AU2, and AU4, containing 0, 1, 2, or 4 copies, respectively, of the destabilizing AUUUA motif. Using these RNAs, NIPP-1 was identified as an RNA-binding protein by several independent criteria. Thus, North-Western analysis showed a binding of denatured NIPP-1 to bacterial 9 S RNA and to the oligoribonucleotides AU4 and AG1 (Fig. 1, left panel). We were also able to obtain a UV-mediated cross-linking of native NIPP-1 to AU4 (Fig. 1, right panel), and to ompA and 9 S RNA (not shown). Following cross-linking of NIPP-1 to AU4, a radioactive band of 50 ± 1 kDa (n = 4) was detected, which corresponds to the combined masses of NIPP-1 (38.5 kDa) and AU4 (10 kDa). In addition, a radioactive band of 130 ± 4 kDa (n = 4) was detected, which might represent a cross-linked AU4-NIPP-1 dimer. No cross-linking was obtained under identical conditions when bovine serum albumin was used instead of NIPP-1 (Fig. 1, right panel).

A binding of NIPP-1 to RNA could also be reproducibly demonstrated by assays of RNA-mobility shifts in native gels, as is illustrated for ompA, 9 S RNA, and AU4 in Fig. 2. Under the same conditions, no RNA band shifts were seen with the control proteins casein, myelin basic protein, bovine serum albumin, and PP-1C (not illustrated). The specificity of the interaction between NIPP-1 and AU4 is also illustrated by the effects of NIPP-1 antibodies and of the antigenic peptide on the mobility shift (Fig. 2). Phosphorylation of NIPP-1 by protein kinase A or casein kinase-2, which decreases its potency as an inhibitor of PP-1C (10-13), had no effect on its ability to induce RNA-mobility shifts (not shown).


Fig. 2. NIPP-1 induces RNA-mobility shifts. 32P-Labeled 9 S RNA, ompA mRNA, or AU4 (1-2 µCi/ml) were incubated for 30 min at 0 °C, as such or in the presence of NIPP-1 (2 µg/ml). Following 5% PAGE, the labeled RNAs were visualized by autoradiography. It is also shown that the NIPP-1-induced mobility shift of AU4 is blocked by a preincubation (15 min at 0 °C) of the mixture with NIPP-1 antibodies (0.1 mg/ml). The latter block was not seen after preincubation (15 min at 30 °C) of the antibodies with an excess of the antigenic peptide (0.1 mg/ml).
[View Larger Version of this Image (35K GIF file)]

Since NIPP-1 is associated with PP-1C in the nucleus (10), it appeared important to determine whether the complex (PP-1NNIPP-1) also displayed RNA-binding properties. In Fig. 3A, it is shown that PP-1C did not bind to poly(U)-Sepharose. In contrast, free NIPP-1 (Fig. 3B) as well as an in vitro reconstituted heterodimeric complex of NIPP-1 and PP-1C (Fig. 3C) was completely retained by the affinity column. The binding of NIPP-1 and PP-1NNIPP-1 to poly(U)-Sepharose was very strong, since they were not eluted at NaCl concentrations up to 1.5 M. NIPP-1 and PP-1NNIPP-1 could subsequently be eluted, however, with 3 M KSCN.


Fig. 3. NIPP-1 and PP-1NNIPP-1 bind to poly(U)-Sepharose. 0.25 nmol PP-1C (panel A), 0.25 nmol NIPP-1 (panel B) or a mixture of both components (panel C) were preincubated for 20 min at 0 °C in a buffer containing 10 mM Tris/HCl at pH 7.4, 1 mM EDTA, 50 mM NaCl, 1 mM dithiothreitol, 0.2 mM phenylmethylsulfonyl fluoride, 0.2 mM benzamidine, 10 µM leupeptin, 50 µM L-1-tosylamido-2-phenylethyl ketone, and 50 µM 1-chloro-3-tosylamido-7-amino-2-heptanone. Subsequently, the samples were applied to a poly(U)-Sepharose column (2 ml), equilibrated in the same buffer. The bound proteins were first eluted with a linear salt gradient (50 to 1,500 mM NaCl) and then with 3 M KSCN. The eluted fractions (1 ml) were dialyzed against the equilibration buffer. PP-1C was localized by the assay of the spontaneous phosphorylase phosphatase activity (panel A). NIPP-1 was assayed as an inhibitor of added PP-1C (panel B). PP-1NNIPP-1 was localized by the assay of spontaneous (open circle ) and trypsin-revealed (bullet ) phosphorylase phosphatase activities.
[View Larger Version of this Image (18K GIF file)]

Specificity for Binding of NIPP-1 to Nucleic Acids

The nonlabeled ribohomopolymers showed a different potency in competing for the binding of NIPP-1 to 5'-end-labeled AU4 at 0.1 µg/ml (Fig. 4). Indeed, while poly(G) was not a competitor at concentrations up to 2.5 µg/ml, poly(U) at only 0.02 µg/ml nearly completely prevented the binding of NIPP-1 to AU4. Poly(A) and poly(C) were less potent.


Fig. 4. Competition of the binding of NIPP-1 to AU4 by ribohomopolymers. NIPP-1 (2 µg/ml) was incubated with 32P-labeled AU4 (0.1 µg/ml) in the presence of the indicated concentrations of nonlabeled poly(A), poly(G), poly(C), or poly(U). Following 5% PAGE, the radioactive AU4 was visualized by autoradiography.
[View Larger Version of this Image (29K GIF file)]

At the same concentrations and specific radioactivities, the AUUUA-containing oligoribonucleotides AU1, AU2, and AU4 bound more NIPP-1 than did AG1, where the AUUUA motif is altered into AGGUA (Fig. 5, upper panel). We did not observe a difference in the affinities for AU1, AU2, and AU4, indicating that their binding to NIPP-1 was not affected by the number of the AUUUA motifs. These findings were corroborated by competition assays with nonlabeled probes, showing that AU2 and AU4 were 5-10 times better than AG1 as competitors for binding of NIPP-1 to AU4 (Fig. 5, lower panel). Combined with the data of Fig. 4, this suggests that NIPP-1 preferentially binds to U-rich RNA.


Fig. 5. NIPP-1 has a high affinity for AUUUA-motifs. 32P-Labeled AG1, AU1, AU2, and AU4, each at 0.1 µg/ml and 1 µCi/ml, were incubated during 30 min at 0 °C in the absence or presence of NIPP-1 (2 µg/ml). The upper panel shows an autoradiogram after 5% PAGE. The lower panel shows the effect of the indicated concentrations of nonlabeled AG1, AU2, or AU4 on the NIPP-1-mediated mobility shift of 32P-labeled AU4 (0.1 µg/ml).
[View Larger Version of this Image (28K GIF file)]

We have also compared RNA and DNA as competitors for binding of NIPP-1 to AU2 at 0.15 µg/ml. In Fig. 6 it is shown that the oligoribonucleotide AU4 and the corresponding deoxyribonucleotide dAT4 were equally efficient competitors. However, the complementary strand of dAT4, i.e. dTA4, was 5-10 times less efficient and the double-stranded dAT4/dTA4 was completely inefficient at concentrations up 2.5 µg/ml.


Fig. 6. NIPP-1 binds to RNA and single-stranded but not double-stranded DNA. NIPP-1 (2 µg/ml) was incubated for 30 min at 0 °C with 32P-labeled AU2 (0.15 µg/ml) in the presence of the indicated concentrations of AU4, dAT4, dTA4, or the dAT4·dTA4 complex. Shown is an autoradiogram of the NIPP-1-induced shift of AU2.
[View Larger Version of this Image (26K GIF file)]

The above experiments were all performed with bacterial RNAs or with designed synthetic oligonucleotides. However, we found that NIPP-1 bound with similar affinity to AU4 and to AUMYC, which comprises the destabilizing AUUUA-repeat motif of the 3'-untranslated region of c-myc mRNA (17), as determined by UV-mediated cross-linking, by AUMYC-mobility shift assays, and by competition for the binding of NIPP-1 to AU4 (not shown).

NIPP-1 Is Not an Endoribonuclease

Since the carboxyl-terminal third of NIPP-1 (Ard-1) has been shown to restore the RNase E functions in some rne mutants in E. coli (see Introduction) and since NIPP-1, like bacterial RNase E (15, 17), has RNA-binding properties (this work), we have investigated whether NIPP-1 also displays an endoribonuclease activity. All tested preparations of purified recombinant NIPP-1 displayed a weak Mg2+-dependent RNase activity toward AU4 and 9 S RNA (not shown), which are known substrates for RNase E (15, 17). However, this RNase-E-like activity could be detected only at NIPP-1 concentrations above 250 nM (10 µg/ml), i.e. three orders of magnitude higher than the concentrations of NIPP-1 that are routinely used for its assay as an inhibitor of PP-1. Moreover, this RNase-E-like activity could be separated from NIPP-1 by gel filtration on Superdex-75. These data indicate that NIPP-1 itself is not an RNase, but co-purifies with trace amounts of an RNase-E-like activity from Sf9 cells.


DISCUSSION

RNA-binding Specificity of NIPP-1

We report here several independent lines of evidence indicating that NIPP-1 is an RNA-binding protein. Thus, NIPP-1 was able to induce RNA-mobility shifts (Figs. 2, 4, 5, 6) and could be covalently bound to RNA by UV-mediated cross-linking (Fig. 1). An interaction of NIPP-1 with RNA could also be demonstrated by NorthWestern analysis (Fig. 1) and by affinity chromatography on poly(U)-Sepharose (Fig. 3). Moreover, the RNA binding was shown to be due to a protein with the same size as NIPP-1 (Fig. 1) and was blocked by NIPP-1-specific antibodies (Fig. 2).

AU4 and dAT4 were equally efficient competitors for the binding of NIPP-1 to AU2 (Fig. 6), suggesting that NIPP-1 has the same affinity for RNA and single-stranded DNA. On the other hand, NIPP-1 showed a clear preference for U-rich oligonucleotides and displayed no affinity for double-stranded nucleic acids (Figs. 4 and 6). Analysis of the primary structure of NIPP-1 did not reveal the presence of known RNA-binding motifs such as the "RNP" motif, the arginine-rich motif, the RGG box, or the KH motif (18). However, it is striking that the amino- and carboxyl-terminal thirds of NIPP-1 are very basic (pI 9-10) and are not needed for the interaction with PP-1C (13). It is therefore tempting to speculate on an electrostatic interaction between nucleic acids and the basic extremities of NIPP-1. However, it is clear that additional binding determinants must exist to account for the specificity of the interaction of NIPP-1 with nucleic acids. It is also important to note that the binding of NIPP-1 to both PP-1C (10) and to RNA (Fig. 1) could still be observed after SDS-PAGE and blotting of NIPP-1, indicating that the RNA- and PP-1C-binding domains resist denaturing procedures.

Is NIPP-1 an RNA-targeting Subunit of PP-1?

Since both NIPP-1 and PP-1NNIPP-1 (but not PP-1C) bind to RNA (Fig. 3), we propose that NIPP-1 functions as an RNA-anchoring subunit of PP-1 and enables the phosphatase to dephosphorylate RNA-associated substrates. The activity of PP-1NNIPP-1 would be regulated through phosphorylation of NIPP-1 by protein kinase A and casein kinase-2, which decrease its affinity for PP-1C (10-12), but has no effect on its association with RNA (present work). The proposed association of PP-1NNIPP-1 with RNA agrees with our findings that the holoenzyme is associated with the nuclear insoluble fraction (8, 10) and can be solubilized by the mere incubation of this fraction with ribohomopolymers.2 The targeting model of PP-1NNIPP-1 is also strikingly similar to that of glycogen-associated PP-1 (PP-1G). Indeed, the latter holoenzyme consists of PP-1C and a glycogen-anchoring G-subunit and the interaction between both polypeptides is controlled by reversible phosphorylation of the G subunit (1, 2, 6, 7).

The RNA-anchoring hypothesis implies that PP-1NNIPP-1 is a physiologically active enzyme. At first glance, this contrasts with findings that NIPP-1 is inhibitory to PP-1C (8, 10). However, it is well known that the effects of the regulatory subunits of PP-1 are substrate-dependent. Thus, the G subunit endows PP-1C with synthase phosphatase activity but decreases its phosphorylase phosphatase activity (1, 6, 7). It has also been reported that inhibitor-2 blocks the dephosphorylation of most, but not all substrates of PP-1C (19). Similarly, we have found that intact NIPP-1 inhibits the dephosphorylation of all five tested substrates of PP-1C, albeit to a different extent (10). Also, a 16-kDa fragment of NIPP-1 was inhibitory to the dephosphorylation of phosphorylase, but actually enhanced the dephosphorylation of histone IIA (8). In conclusion, it is possible that NIPP-1 is not a true inhibitor of PP-1, but rather acts as a "substrate-specifying" subunit in vivo. The effects of phosphorylation of NIPP-1 by protein kinase A or casein kinase-2 may have to be reinterpreted along the same lines. Indeed, phosphorylation of NIPP-1 reduces its affinity for PP-1C but, depending on the physiological role of NIPP-1, such phosphorylation may cause an activation or inactivation of PP-1NNIPP-1.

Among the most likely substrates of PP-1NNIPP-1 are the SR-splicing factors, which have been shown to be dephosphorylated by PP-1C in vitro and to reverse the inhibition of spliceosome assembly by PP-1C (3, 4). Interestingly, the described effects of PP-1C on spliceosome assembly and splicing in cell extracts and in permeabilized cells were all obtained at rather high concentrations of the phosphatase (3, 4), which may indicate a requirement for a substrate-specifying and -anchoring subunit. It will be interesting to investigate whether NIPP-1 might promote the dephosphorylation of SR proteins by PP-1C.

NIPP-1 displayed a particularly high affinity for AUUUA sequences (Fig. 5). These are destabilizing motifs in the 3'-end of short-lived mRNAs encoding human (proto)-oncogenes and growth factors (20). The same sequences have recently also been identified as destabilizing motifs in snRNAs (21). The AUUUA motif is specifically cleaved by RNase E from E. coli as well as from mammalian cells (17). In E. coli, RNase E is part of a large RNA-degradation complex, called the degradosome (22). We speculate therefore that PP-1NNIPP-1 takes part in the control of RNA processing in mammalian cells by the dephosphorylation of polypeptides, like RNase E, that are part of a putative mammalian degradosome. It is also important to point out here that, while NIPP-1 is highly enriched in the nucleus, both cell fractionation (13) and immunofluorescence studies2 show the existence of a cytoplasmic pool of NIPP-1. Thus, NIPP-1 could control RNA-processing in the cytoplasmic as well as the nuclear cell compartment.


FOOTNOTES

*   This work was supported by the Algemene Spaar- en Lijfrentekas, by the Belgian Fund for Medical Scientific Research (Grant G.0179.97), by a Flemish Concerted Research Action, and by grants of the Austrian Science Foundation FWF (to A. v. G.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Dagger    Postdoctoral Fellow of the Fund for Scientific Research-Flanders.
   To whom correspondence should be addressed: Afdeling Biochemie, Campus Gasthuisberg KULeuven, B-3000 Leuven, Belgium. Tel.: 32-16-34-57-01; Fax: 32-16-34-59-95; E-mail: Mathieu.Bollen@med.KULeuven.ac.Be.
1   The abbreviations used are: PP-1, protein phosphatase-1; PP-1C, catalytic subunit of PP-1; NIPP-1, nuclear inhibitor of protein phosphatase-1; PP-1NNIPP-1, complex of PP-1C and NIPP-1; snRNPs, small nuclear ribonucleoproteins; PAGE, polyacrylamide gel electrophoresis; ompA, outer membrane protein A.
2   A. Van Eynde, I. Jagiello, M. Beullens, V. Vulsteke, S. Wera, W. Stalmans, and M. Bollen, unpublished data.
3   V. Vulsteke, manuscript in preparation.

ACKNOWLEDGEMENTS

V. Feytons, N. Sente and P. Vermaelen are acknowledged for expert technical assistance. We thank Drs. D. Angerer and Dr. J. Kaszuba (Vienna) for helpful advice in setting up the initial RNA-binding experiments.


Note added in proof

It was recently reported by Claverie-Martin et al. (Claverie-Martin, F., Wang, M., and Cohen, S. N. (1997) J. Biol. Chem. 272, 13823-13828) that Ard-1 is an RNA-binding protein but, in contrast to NIPP-1 (this work), also displays a Mg2+-dependent endoribonuclease activity.


REFERENCES

  1. Bollen, M., and Stalmans, W. (1992) Crit. Rev. Biochem. Mol. Biol. 27, 227-281 [Abstract]
  2. DePaoli,-Roach, A. A., Park, I.-K., Cerovsky, V., Csortos, C., Durbin, S. D., Kuntz, M. J., Sitikov, A., Tang, P. M., Verin, A., and Zolnierowicz, S. (1994) Adv. Enzyme Regul. 34, 199-224 [CrossRef][Medline] [Order article via Infotrieve]
  3. Mistelli, T., and Spector, D. L. (1996) Mol. Biol. Cell 7, 1559-1572 [Abstract]
  4. Mermoud, J. E., Cohen, P. T. W., and Lamond, A. I. (1994) EMBO J. 13, 5679-5688 [Abstract]
  5. Cardinali, B., Cohen, P. T. W., and Lamond, A. I. (1994) FEBS Lett. 352, 276-280 [CrossRef][Medline] [Order article via Infotrieve]
  6. Hubbard, M. J., and Cohen, P. (1993) Trends Biochem. Sci. 18, 172-177 [CrossRef][Medline] [Order article via Infotrieve]
  7. Johnson, D. F., Moorhead, G., Caudwell, F. B., Cohen, P., Chen, Y. H., Chen, M. X., and Cohen, P. T. W. (1996) Eur. J. Biochem. 239, 317-325 [Abstract]
  8. Beullens, M., Van Eynde, A., Stalmans, W., and Bollen, M. (1992) J. Biol. Chem. 267, 16538-16544 [Abstract/Free Full Text]
  9. Dinischiotu, A., Beullens, M., Stalmans, W., and Bollen, M. (1997) FEBS Lett. 402, 141-144 [CrossRef][Medline] [Order article via Infotrieve]
  10. Jagiello, I., Beullens, M., Stalmans, W., and Bollen, M. (1995) J. Biol. Chem. 270, 17257-17263 [Abstract/Free Full Text]
  11. Beullens, M., Van Eynde, A., Bollen, M., and Stalmans, W. (1993) J. Biol. Chem. 268, 13172-13177 [Abstract/Free Full Text]
  12. Van Eynde, A., Beullens, M., Stalmans, W., and Bollen, M. (1994) Biochem. J. 297, 447-449 [Medline] [Order article via Infotrieve]
  13. Van Eynde, A., Wera, S., Beullens, M., Torrekens, S., Van Leuven, F., Stalmans, W., and Bollen, M. (1995) J. Biol. Chem. 270, 28068-28074 [Abstract/Free Full Text]
  14. Will, C. L., Fabrizio, P., and Lührmann, R. (1995) Nucleic Acids Mol. Biol. 9, 342-372
  15. Wang, M., and Cohen, S. N. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 10591-10595 [Abstract/Free Full Text]
  16. Bradford, M. M. (1976) Anal. Biochem. 72, 248-254 [CrossRef][Medline] [Order article via Infotrieve]
  17. Wennborg, A., Sohlberg, B., Angerer, D., Klein, G., and von Gabain, A. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 7322-7326 [Abstract]
  18. Burd, C. G., and Dreyfuss, G. (1994) Science 265, 615-621 [Medline] [Order article via Infotrieve]
  19. Alessi, D. R., Street, A. J., Cohen, P., and Cohen, P. T. W. (1993) Eur. J. Biochem. 213, 1055-1066 [Abstract]
  20. Shiavi, S. C., Belasco, J. G., and Greenberg, M. E. (1992) Biochim. Biophys. Acta 1114, 95-106 [CrossRef][Medline] [Order article via Infotrieve]
  21. Fan, X. C., Myer, V. E., and Steitz, J. A. (1996) Abstracts of the RNA'96, First Annual Meeting of the RNA Society, University of Wisconsin-Madison, May 28-June 2, p. 208
  22. Py, B., Higgins, C. F., Krisch, H. M., and Carpousis, A. J. (1996) Nature 381, 169-172 [CrossRef][Medline] [Order article via Infotrieve]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.